Calcium-responsive transcription factor (CARF)

Calcium-responsive transcription factor (CARF) is a neuronal transcription factor activated by increases in intracellular calcium, especially following synaptic activity in neurons[1][2]. CARF enables DNA binding and acts as a transcriptional activator—notably at brain-derived neurotrophic factor (BDNF) promoter regions where it regulates the neuron-specific, activity-dependent expression of BDNF[1][2]. It has a unique DNA-binding domain with no significant homology to other transcription factors[2]. CARF loss in mouse models leads to altered BDNF expression, disturbances in GABAergic synapse protein levels, and varied behavioral effects such as changed learning, memory, and cognitive flexibility, demonstrating its central role in brain development and function[1]. Although originally mapped to a genomic region associated with juvenile amyotrophic lateral sclerosis (ALS2CR8), there is currently no direct link to ALS pathogenesis established in the literature[1][2]. No drugs are currently known to target or modulate CARF activity directly. CARF is a unique, evolutionarily conserved transcription factor with major roles in neuronal activity-regulated gene expression and neural plasticity[1][2]. It is not a typical therapeutic target (such as a receptor or enzyme); no pharmacological agents target it directly, and no clinical biomarkers or safety issues are described for it[1][2]. Its aliases also reflect its chromosomal location and putative involvement in ALS2, but evidence for direct disease causality is lacking[1][2].

Other names

ALS2CR8CaRFFLJ21579NYD-SP24Calcium-response factorTestis development protein NYD-SP24Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 8 protein